Validation & Customer Pipeline
DSO validation and go-to-market strategy
Technology Validation
DSO National Laboratories Feasibility Study
NuBatt's technology has been validated through a completed feasibility study with DSO National Laboratories, Singapore's premier defence research organisation.
Engagement Overview
| Aspect | Details |
|---|---|
| Partner | DSO National Laboratories (Singapore) |
| Contract Reference | PO62504138 |
| Scope | Technical feasibility study for UAV power applications |
| Status | Completed |
| Product Focus | NuBatt-L1 (Liquid Transducer with Am-241) |
Study Scope and Objectives
Technical Feasibility: Can nuclear voltaic technology deliver required power for UAV applications?
Shielding Design: Can radiation be contained to safe levels within acceptable weight/size?
Safety Compliance: Does the design meet IAEA and international safety thresholds?
Practical Implementation: What are the manufacturing and operational considerations?
Validation Methodology
| Method | Application | Outcome |
|---|---|---|
| MCNP Simulations | Monte Carlo N-Particle radiation transport modelling | Validated shielding effectiveness |
| Half-Value Layer (HVL) Analysis | Shielding thickness calculations | Confirmed design margins |
| NIST XCOM Database | Material attenuation coefficients | Validated material selections |
| Dose Rate Calculations | Safety compliance verification | Confirmed regulatory compliance |
Key Results
Safety Validated: Dose rate at 1m is 4.3x below IAEA threshold with shielding effectiveness exceeding requirements.
| Validation Area | Result | Margin |
|---|---|---|
| Dose Rate at 1m | <0.1 μSv/h | 4.3× below IAEA threshold |
| Shielding Effectiveness | 29.8 HVL provided | Exceeds 27.7 HVL required |
| MCNP Simulation | Confirmed empirical calculations | Validated |
| Safety Compliance | Meets IAEA Basic Safety Standards | Confirmed |
Validated Design Specifications
| Parameter | Specification |
|---|---|
| Module Dimensions | 401.5 × 401.5 × 72 mm |
| Pack Dimensions | 462 × 462 × 360 mm |
| Pack Weight | ~21 kg |
| Isotope | Am-241 (11.5 kg) |
| Shielding Materials | SiO₂, HDPyC, Stainless Steel, Tungsten |
Significance of DSO Validation
Technical Credibility
Government defence laboratory confirmed feasibility
Safety Assurance
Independently validated radiation safety compliance
Design Validation
Specifications confirmed through rigorous simulation
Customer Reference
Established relationship with Singapore defence ecosystem
Pathway Clarity
Demonstrated regulatory compliance approach
Technical Validation Summary
Validated Technology Elements
| Element | Validation Status | Method |
|---|---|---|
| Am-241 Alpha-Voltaic Concept | Validated | DSO Study |
| Liquid Transducer Technology | Feasibility Confirmed | Design Analysis |
| Multi-Layer Shielding | Validated | MCNP, HVL |
| Dose Rate Compliance | Confirmed | Empirical + Simulation |
| Form Factor (UAV) | Specified | Engineering Design |
Safety Validation
| Safety Aspect | Validation | Result |
|---|---|---|
| External Dose Rate | MCNP simulation + calculation | 4.3× below limits |
| Shielding Integrity | Multi-layer design analysis | Robust |
| Containment | Sealed construction | Zero release |
| IAEA Compliance | GSR Part 3 assessment | Compliant |
Industry Interest in Nuclear Voltaic Technology
Background Context
The underlying nuclear voltaic technology platform has attracted interest from major aerospace, defence, and technology organisations. While these represent engagements with NDB Inc. (NuBatt's technology licensor) rather than direct NuBatt contracts, they demonstrate market interest in the technology class.
Industry Validation Indicators
Major defence contractors have expressed interest in long-endurance power solutions
Research Institution Engagement
The technology platform has been validated through research collaborations with leading institutions:
| Institution | Relevance |
|---|---|
| Oak Ridge National Laboratory | US DOE nuclear research centre |
| Brookhaven National Laboratory | US DOE physics research |
| CERN | European particle physics research |
| EPFL | Swiss technical university |
Note: These represent NDB research relationships demonstrating technology credibility, not NuBatt commercial contracts.
Customer Development Strategy
Target Customer Segments
| Target | Approach | Value Proposition |
|---|---|---|
| Singapore Defence | Build on DSO relationship | Validated technology, local presence |
| Allied Nations | Government-to-government channels | Long-endurance UAV/sensor power |
| Space Agencies | Commercial space partnerships | RTG alternative |
Customer Pipeline Development
Partnership Strategy
Partnership Model Framework
| Model | Structure | Target Partners |
|---|---|---|
| Technology Licensing | IP license for specific applications/regions | OEMs, regional partners |
| Joint Development | Co-investment in product adaptation | Aerospace primes, medical device companies |
| Supply Agreements | Long-term isotope/component supply | Energy companies, industrial conglomerates |
| Distribution | Channel partnerships | Regional distributors, integrators |
Target Partner Categories
Sales Cycle Considerations
Defence Market
| Characteristic | Implication |
|---|---|
| Long Cycle | 18-36+ months from initial contact to contract |
| High Value | Large contract values justify long sales investment |
| Government Process | Procurement regulations, security clearances |
| Technical Depth | Extensive validation and testing requirements |
| Relationship Driven | Past performance and trust critical |
NuBatt Advantage: DSO validation provides entry point and reference.
Aerospace Market
| Characteristic | Implication |
|---|---|
| Technical Validation | Extensive qualification testing required |
| Certification | Aerospace standards compliance (AS9100, etc.) |
| Long Integration | 12-24+ months for platform integration |
| Risk Averse | Established technology preference |
NuBatt Advantage: MCNP-validated designs reduce technical risk perception.
Medical Device Market
| Characteristic | Implication |
|---|---|
| Regulatory Intensive | FDA/CE marking, clinical trials |
| Long Approval | 3-7+ years from development to market |
| Licensing Model | OEM partnership more efficient than direct |
| High Standards | Biocompatibility, reliability requirements |
NuBatt Advantage: Licensing model allows focus on core technology.
Industrial Market
| Characteristic | Implication |
|---|---|
| Faster Cycle | 6-12 months for pilot to deployment |
| Proof-of-Concept | Demonstrate value in specific application |
| ROI Driven | Clear business case required |
| Scalable | Initial deployment leads to broader adoption |
NuBatt Advantage: Clear total cost of ownership advantage for long-duration applications.
Go-to-Market Approach
Phase 1: Defence Anchor (2026-2027)
Focus: Establish production capability and deliver first defence contracts
| Activity | Target |
|---|---|
| Build on DSO relationship | Singapore defence ecosystem penetration |
| Engage allied defence agencies | International defence pipeline |
| Complete production facility | Manufacturing capability |
| Deliver first units | Reference deployments |
Phase 2: Commercial Initiation (2027-2028)
Focus: Establish commercial partnerships and isotope operations
| Activity | Target |
|---|---|
| Medical device partnerships | OEM licensing agreements |
| Isotope production | Medical isotope supply contracts |
| Aerospace discussions | Development partnership initiation |
| IoT pilots | Industrial sensor deployments |
Phase 3: Scale Operations (2029+)
Focus: Scale across all market segments
| Activity | Target |
|---|---|
| Production scaling | Volume manufacturing |
| Geographic expansion | International sales operations |
| Full portfolio | All product lines commercially available |
| Licensing growth | Regional and application licenses |
Summary
NuBatt's customer development strategy is built on validated technology, an established defence entry point, and a clear phased go-to-market approach.
| Foundation | Status |
|---|---|
| Technology Validation | DSO Singapore feasibility study completed |
| Defence Entry Point | Established relationship and reference |
| Market Interest | Underlying technology attracting industry attention |
| Clear Go-to-Market | Phased approach from defence to commercial |
| Partnership Strategy | Multiple models for different market segments |
The DSO validation provides a strong foundation for customer development, demonstrating both technical feasibility and regulatory compliance to prospective customers across defence, aerospace, medical, and industrial markets.
[End of Validation & Customer Pipeline]